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Abstract
Reactive oxygen species (ROS) are key signaling molecules that play an important role 
in the progression of inflammatory disorders. In the last decade, studies have indicated 
that ROS, including superoxide and hydrogen peroxide, are crucial components that 
regulate the differentiation process of osteoclasts. Osteoclasts (OCs), cells specialized for 
bone resorption, utilize ROS as second messengers during receptor activator of NF-κB 
ligand (RANKL)-induced differentiation and activation. The purpose of this chapter is 
to explore the current understanding of reactive oxygen species involvement in bone 
pathophysiology.
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1. Introduction
Reactive oxygen species (ROS) are known to determine oxide-reducing balance alteration, oxi-
dative stress, and carcinogenicity. Many diseases, including cancer and other pathologies asso-
ciated, like arteriosclerosis and cataracts, are related to mitochondrial dysfunctions provoked 
by reactive oxygen species [1, 2]. Free radicals (O2−, HO•, H
2
O
2
) react easily and cause damage 
to the DNA and cell membranes, generating strong oxidant agents inside cells [3]. Reactive oxy-
gen species (ROS) play a role in a number of degenerative conditions including osteoporosis [4].
Bone is an important organ performing three essential physiological functions: mechanical 
support, mineral homeostasis, and support of hematopoiesis. Bone diseases in the elderly are 
associated with increased morbidity and mortality. Osteoporosis is one of the most important 
diseases that affects the quality of life for the elderly [5]. Although the bones stop growing 
after adolescence, the bone is a very dynamic tissue. Bone tissue is continuously reabsorbed 
and regenerated by constantly changing its structure.
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One of the most striking features of the bones is their ability to reshape. This remodeling 
process occurs during growth and continues throughout its life. During bone formation, the 
bone is formed and deposited, according to a particular pattern, by a process called ossifi-
cation. The remodeling is continuous, leading to the organization of the bone structure in 
regular units, allowing the bone mass to gain maximum resistance to the mechanical forces 
acting on it. The older bone is removed by osteoclasts (bone-resorbing cells), and osteoblasts 
(bone-forming cells) lead to the deposition of new bone tissue. Osteoclasts secrete enzymes 
that break down the bone matrix as effectively as acids and convert calcium salts resulting in 
a soluble form (that can be absorbed into the bloodstream).
Osteoclast activity occurs behind the epiphyseal growth zone to reduce bone margins enlarged 
at the width of the bone stem that undergoes an elongation process.
The remodeling process is especially important for long bones supporting the limbs. These bones 
are widest at the ends and narrower in the middle, which gives added strength to the joints.
As osteoclasts destroy the old bone at the epithelial ends of the bone, the osteoblasts within 
the growth zone create a new epiphysis.
In each of the tubular spaces released by osteoclasts within the bone, the osteoblasts come in 
to deposit a new bone layer.
A bone that is poorly used, such as a lower immobilized member after a trauma, will be prone 
to reabsorption because bone destruction goes beyond bone formation.
Bones subjected to increased stress are permanently remodeled. The femur, for example, is 
completely replaced every 6 months.
Bone remodeling gives the different form of long bones. They are wider at each end and 
thinner in the middle. Bone remodeling not only changes the bone structure but also helps 
regulate the level of ionic calcium in the blood. Calcium is necessary for normal nervous 
transmission, for cell membrane formation, and for blood clotting. The resorption and bone 
formation sequence is shown in Figure 1.
Osteoblasts (bone-forming cells), osteoclasts (bone-resorbing cells), and osteocytes (load-
sensing cells) are the cell types participating in bone remodeling. During remodeling, these 
cell types are spatially and temporally organized in functional structures called basic mul-
ticellular units (BMUs). The remodeling sequence operated by a BMU follows well-defined 
phases [5]. The bone remodeling sequence is influenced by a number of regulatory factors 
produced by hormonal glands, bone cells involved in sensing the mechanical environment, 
lymphocytes, and even tumor cells [6].
Osteoporosis is characterized by the parallel reduction of bone minerals and bone matrix so 
that the bone is in a low amount but with a normal percentage composition.
Despite rapid advances in our understanding over the last few years, the morbidity and mor-
tality of patients resulting from this disease are still too high [4], and there is an urgent need 
for a proper assessment of the underlying mechanisms and the development of new treat-
ment strategies to address this pathophysiological issue.
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2. Reactive oxygen species
Oxygen (O
2
), nitrogen oxide (NO), and iron (Fe2+) are present in erythrocytes. These elements 
may in some conditions form reactive species, called radicals that affect red blood cells and 
vascular endothelium. A chemical species that presents an unpaired electron in outer orbitals 
and which can exist independently is called free radical. Radicals are very reactive trying to 
complete their own orbits by taking an electron from a neighboring molecule. Oxygen and 
nitrogen are the two chemical elements that in the body give rise to reactive species called the 
reactive oxygen species (ROS) and reactive nitrogen species (RNS), respectively.
2.1. ROS: general definitions
Reactive species can be defined as atoms or molecules that contain in their structure an odd 
electron that causes an atom/molecule energy instability, which is reflected in their increased 
reactivity.
Reactive species are produced in the body for physiological purposes in defense, vaso-relax-
ation, cellular or accidental exposure to toxic, or radiation exposure. When the amount of 
reactive species exceeds nontoxic physiological levels, the so-called oxidative stress occurs. 
Oxidative stress can be defined as the status of reactive oxygen or oxygen radicals in a bio-
logical system. It results from the imbalance between oxidants and antioxidants, in favor of 
oxidants, with destructive and pathogenic potential [7, 8].
The reactive species of oxygen are superoxide (O
2
•−), hydrogen peroxide (H
2
O
2
), hydroxyl 
radical (OH•), and singlet oxygen (1O
2
). Free oxygen radicals (ROS) produce harmful effects 
on the body called oxidative stress (OxS). The reactive oxygen species are constantly formed 
as reaction products in all cells by aerobic processes such as oxidative phosphorylation.
Figure 1. Bone remodeling sequence executed by different bone cell types within basic multicellular units (BMUs) 
(figure from Ref. [5], reproduced with permission).
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The base state of oxygen is triplet. This means that it has two unpaired electrons that are posi-
tioned on two different molecular orbitals.
Because electrons have parallel spin, oxygen can only rotate in the same orbit. Since molecular 
oxygen is paramagnetic, it is concluded that it has the structure represented in the right-hand 
side of Figure 2. Molecular oxygen can react rapidly with single unpaired electrons of transi-
tory metals (e.g., Fe, Cu, Mn). One mole of properly chelated copper could catalyze consump-
tion of the oxygen in an average room within 1 s in [9]. Depending on the conditions, O
2
 can 
be both kinetically stable (not reactive) and very reactive.
For proteins and enzymes that have a metal in their structure, the oxidative attack of O
2
 is 
slow, and in conclusion the superoxide radical will slowly form.
Superoxide (O
2
): this radical constitutes the first step of oxygen activation by way of univalent 
reduction, forming in most of the autoxidation reactions by the capture of an electron that is 
placed on one of the antiknocking orbital n (Figure 3).
After an electron has been acquired, the following electrons are added more easily, and the 
reactions take place faster, leading to the generation of reactive oxygen species [10].
Reducing the hydroxyl radical to water takes place in the last stage of electron acceptance 
(Figure 4).
Superoxide radical (O
2
) can react in the presence of ferric iron with hydrogen peroxide gener-
ating the most potent hydroxyl radical through a nonenzymatic reaction named Haber-Weiss 
reaction.
Figure 3. Superoxide radical generation.
Figure 2. The structure of oxygen molecule.
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The reaction involves two steps:
  O 
2
 +  Fe 3+  →  O 
2
 +  Fe 2+ (1)
  Fe 2+ +  H 
2
   O 
2
  →  Fe 3+ +  OH − +  OH • (2)
The nonenzymatic reaction occurring in living cells is:
  O 
2
 +  H 
2
   O 
2
  →  OH • +  OH − +  O 
2
 (3)
In the presence of ferric iron, superoxide radical is a source of hydroxyl radical.
Most of the superoxide radicals are formed by electrons derived from the coenzyme Q cycle 
in complex III and by NADH flavoprotein dehydrogenase (complex I). The superoxide radi-
cal, which has a relatively low degree of toxicity compared to other reactive oxygen species, is 
kept undetected by enzymes called superoxide dismutase (SOD) that catalyzes the dismuta-
tion reaction.
Hydrogen peroxide (H
2
O
2
) is not a free radical due to the fact that it has no unpaired electron 
in the structure, which gives it reactive stability, being the most easily measurable reactive 
species. H
2
O
2
 is a weak oxidizing agent that forms as a result of the O
2
-dismutation reac-
tions or oxidase-catalyzed reactions. This process takes place at the level of peroxisomes, 
cellular organisms with rich enzyme equipment. Concentration of hydrogen peroxide is 
controlled by catalase (present in peroxisomes) and by glutathione peroxidase (localized to 
the cytosol).
Hydroxyl radical (OH•) is a highly reactive free radical which diffuses over small distances 
until it reacts with any organic molecule encountered such as carbohydrates, amino acids, 
lipids, nucleic acids, and organic acids. The toxicity of this molecule comes from the fact that 
it can initiate chain reaction.
Singlet oxygen (1O
2
) can result from oxidoreduction reactions. Single oxygen is more reactive 
than the hydroxyl radical by reacting with many organic compounds such as polyunsatu-
rated fatty acids, cholesterol-forming hydroperoxides.
Figure 4. Reactive oxygen species generation.
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Singlet oxygen can be formed from superoxide radical in [11]:
  2O 
2
 +  2H + → H 
2
   O 
2
   + 1   O 
2
 (4)
Although it is not a radical, singlet oxygen is more reactive than the hydroxyl radical. The 
most reactive radical is hydroxyl (OH•) which takes electrons from other molecules around it, 
whereas superoxide (O
2
) and hydrogen peroxide (H
2
O
2
) are more selective in their reactions 
with various molecules [12].
The processes so far presented above take place in all human cells. The molecular oxygen that 
is transported to the tissues is found for a short period of time unbound. It is assumed that in 
this state, it generates the radicals previously presented. Oxygen binds to hemoglobin mole-
cule at the ferrous iron (Fe2+). Some of Fe2+ is transformed by O
2
 to ferric form (Fe3+) in resulting 
methemoglobin. Methemoglobin reductase is an enzymatic system which restores Fe3+ to Fe2+ 
and reduces methemoglobin back to hemoglobin. Oxygenated hem has some of the electronic 
characteristics of a Fe3+OO peroxide anion [10]. Like in this study [13], the author found that 
the Fe3+O2− complex is able to generate superoxide radical during the normal molecular oxy-
gen transport to tissues through the hemoglobin auto-oxidation.
Some researchers propose that hemoglobin may have oxidative reaction in the oxygen-releas-
ing process.
Like in this study from 2006 [14], the author demonstrates that at intermediate oxygen pres-
sure, where hemoglobin partially releases molecular oxygen, the superoxide radical produc-
tion increases. They show that superoxide radical is released in the hydrophobic hem pocket.
Through the Haber-Weiss reaction, H
2
O
2
, even if it is not a radical, can form short and very 
active hydroxyl radicals [15]. The hydroxyl radical (OH•), which is highly reactive, reacts with 
any biomolecules it encounters. There are studies according to which the high reactivity of the 
hydroxyl radical decreases its ability to diffuse [16]. Since the hydroxyl radical may generate 
an autocatalytic reaction in the chain, we can say that it is particularly dangerous.
There are some researchers who believe that the hydroxyl radical is responsible for cellular 
damage and others that ferric ion promotes initiation of the chain reaction [17–19]. In conclu-
sion, both oxidative species can form in living cells [20].
Like in Figure 4, ROS are produced accidentally and physiologically in various enzyme-cat-
alyzed reactions.
2.2. Effects and signaling of ROS
Reactive oxygen species can interact with any biological molecule causing damage to lipids, 
proteins, and DNA. Prospects for effective therapeutic intervention may fail if the initial tar-
get of oxidative stress is unknown. For example, it is known that DNA is the primary target 
of lesions produced by the addition of H
2
O
2
 to mammalian cell cultures, so that DNA strand 
breaks occur before lipid peroxides or “detectable” oxidized proteins. The method of detect-
ing lesions produced on target molecules may give incomplete information. The evidence of 
protein damage by detecting carbonyl radicals in the initial stages of lesions may be negative, 
but the determination of SH oxidation, which occurs earlier, is positive. During peroxidation 
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of lipids, the peroxyl radicals are formed by chain reactions. These intermediates that are 
formed can amplify the lesion. The attack of ROS affects both erythrocytes and  endothelial 
cells. DNA damage may occur in nucleus containing endothelium cell besides lipid and 
 protein oxidation. Interaction between free radicals and DNA can lead to strand breaks or 
structural changes such as adduct formation (Figure 5) [21, 22].
In general, lipid peroxidation occurs in late stages of aggression, so therapies directed against 
lipoperoxidation may be less beneficial. This is another reason that can lead to erroneous con-
clusions about the importance of oxidative stress and antioxidant therapies.
As long as they do not accumulate in excess, ROS have positive effects in the body, being 
involved in various cellular mechanisms. For example, biosynthesis of thyroid hormones 
involves the formation of hydrogen peroxide in order to assemble thyroglobulin iodine to 
synthesize thyroxine. On the other hand, in the immune response, in neutrophils and mac-
rophages, NADPH oxidase catalyzes the formation of superoxide anion by internalizing 
Figure 5. ROS damaging activity.
Figure 6. Cells response under ROS attack [23].
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bacterial antigenic structures. The process is completed by the action of SOD, which will 
produce hydrogen peroxide that will induce bacterial lysis. It has been shown that ROS acts 
as a signaling molecule [21, 22]. In response to the intensity of attack of the ROS, cellular 
responses are triggered, which prepare the cells to survive or to die (Figure 6).
Oxidative stress can trigger cellular response through different signaling modes. ROS modu-
lates different types of enzymes, the activity of transcription factors, and the ionic channel. 
Both kinases and phosphatases can be modulated by ROS.
Mitogen-activated protein kinase (MAPK), which has three subfamilies, namely, N-terminal 
c-Jun kinase (JNK), p38 MAPK, and extracellular signal-regulated kinase (ERK), is part of the 
kinase class [24]. These MAPK pathways are structurally the same. The difference between 
them is found at a functional level. ROS activates these three MAPK pathways [25] and may 
inhibit tyrosine phosphatase activity.
In gene and protein expression, ROS are involved by activating transcription factors.
The plasma membrane Ca2+ and K+ channels are stimulated by ROS. The increase in calcium 
ion concentration ROS mediated leads to the oxidative stress-mediated activation of PKC and 
to the transcriptional induction of the AP-1 proteins c-Fos and c-Jun [26].
Cells can be protected from attack by reactive species through various mechanisms. 
Antioxidants can be divided into two groups: enzymatic like superoxide dismutase (SOD), 
glutathione peroxidase (GPx), and catalase and nonenzymatic like vitamins E and C, provita-
min A (b-carotene), and glutathione.
SOD is found in all aerobic cells as well as in aerobic optional bacteria. Initially, it was inter-
preted as a copper storage form, and later three types of SODs were described, based on the 
type of metal in the catalyst center.
The role of superoxide dismutase is to catalyze the dismutation reaction of the superoxide 
radical anion according to the equation (Figure 7):
The enzyme may also inhibit the production of singlet oxygen and indirectly the peroxidation 
of polyunsaturated fatty acids. In addition to the role of the oxidative marker, SOD is tested as 
a potential therapeutic agent under pathological conditions in which the oxidative stress has a 
clear role, such as ischemia-reperfusion syndromes, hepatic disorders and acute and chronic 
inflammation, cataracts, rheumatic arthritis, diabetes, and neoplasia. One of the enzyme-cata-
lyzed reactions leads to the appearance of another harmful compound—hydrogen peroxide [27].
GPx is part of a family of enzymes catalyzing the degradation of H
2
O
2
 resulting from normal 
metabolic processes and providing the protection of proteins, lipids, and nucleic acids from 
the action of oxidizing molecules, using glutathione as an electron donor or, in some cases, 
thioredoxin or glutaredoxin (Figure 8).
Figure 7. Superoxide dismutase activity.
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GPx is a dependent selenium enzyme, found in cytosol (70%) and in mitochondria (30%). 
It is irreplaceable in the antioxidant arsenal, especially in mitochondria, as they do not con-
tain catalase for peroxide metabolism. GPx also provides protection against organic H
2
O
2
 
and helps to regenerate the reduced vitamin C form. Imbalances in the GPx level have been 
observed with aging and a variety of disorders such as cancer, cardiovascular disease, and 
diabetes [28].
GPx is an enzyme that has a potentially greater antioxidant than SOD and catalase due to 
the wide-specific substrate. Other roles of GPx are regulating prostaglandin biosynthesis by 
inhibiting lipoxygenase and, in conjunction with glutathione reductase, contributing to the 
restoration of reduced glutathione.
3. Oxidative stress in bone remodeling
Bone tissue undergoes, throughout life, a continuous renewal through a process called bone remod-
eling, which is controlled by the activity of osteoclasts mediating bone resorption and parallel 
activity of osteoblasts which mediate bone formation [29]. A bone remodeling cycle involves three 
stages: (1) initiation, during which osteoclasts are formed and resorb damaged bone; (2) reversal, 
the transition of osteoclast to osteoblast activity; and (3) formation, when osteoblasts replace the 
portion of the bone that was resorbed [30]. The hormonal imbalance or the aging process can lead 
to disruption of the balanced formation process and bone resorption. This may result in decreased 
bone mass and osteoporosis, which increases the risk of fractures. A very important factor under-
lying the pathogenesis of osteoporosis is the receptor activator of NF-κB ligand (RANKL). It plays 
an important role in osteoclast differentiation and activation [31]. For this reason, inhibition of 
RANKL represents an innovative therapeutic target for controlling osteoclastogenesis [32].
In the bone remodeling process, the alternative NF-κB pathway, which mediates the activa-
tion of the p52/RelB NF-κB complex, is involved. The difference of the alternative mecha-
nism is represented by p100 processing of a NF-κB2 precursor protein. Both NF-κB-inducing 
kinase (NIK) and IKKα, a downstream kinase, promote induction of phosphorylation-depen-
dent ubiquitination for p100. NF-κB-inducing kinase is processed by a tumor necrosis factor 
(TNF) receptor-associated factor-3 (TRAF3)-dependent E3 ubiquitin ligase. NIK activates the 
alternative path of NF-kB. This occurs after signals mediated by a subset of TNF receptor 
superfamily members [33]. The inhibitory role of p100, in both basal and stimulated osteoclas-
togenesis in bone formation and resorption, has been clearly demonstrated [34]. In the alter-
native NF-κB pathway p52 derived from p100 through NIK, binding of p52 and RelB induces 
effects on osteoclast biology [34]. However, to date, the precise physiologic importance of 
Figure 8. Glutathione peroxidase activity.
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alternative NF-κB in bone biology is not completely elucidated. Furthermore, the currently 
known intracellular signaling pathways activated after receptor binding of RANKL include 
the nuclear factor of activated T cells [35], mitogen-activated protein kinases (MAPKs), TRAFs, 
c-Jun N-terminal kinases (JNKs), and ROS [36, 37]. In addition, NF-κB is a transcription factor, 
which pleiotropically regulates osteoclast formation, function, and survival [35].
The reactive oxygen species are involved in the regulation of RANKL-dependent osteoclast 
differentiation. They act as intracellular signaling compounds. ROS have cytotoxic effects, 
including lipid peroxidation and DNA damage.
Since the relationship between Nrf2 and osteoclastogenesis is known, stimulation of precur-
sors of osteoclasts with RANKL will lead to the upregulation of Keap1 and downregulation 
of cytoprotective enzymes. Osteoclast precursors are primary peritoneal macrophages and 
RAW 264.7 cells. Keap 1 is a negative regulator of Nrf2. However, overexpression of Nrf2 
leads to the regulation of the expression of heme oxygenase-1 and gamma-glutamylcysteine 
synthetase enzymes associated with decreased reactive oxygen species and slowing of bone 
destruction [38]. Consistent with this line of evidence, overexpression of Keap1 or RNAi-
induced knockdown of Nrf2 resulted in effects opposite to those obtained by stimulation 
of Nrf2-dependent DNA binding activity [38]. We still do not know the exact mechanisms 
by which RANKL stimulation reduces Nrf2. It is known that Keap1 has in its structure thiol 
groups. These groups are highly reactive, and oxidation at their level produces conforma-
tional changes to Keap1. Ultimately these will lead to dissociation from Nrf2 and promotion 
of nuclear Nrf2-dependent DNA binding activity [38].
In addition, Nrf2 autoregulates its own expression [39–41]. Taken together, this evidence 
implies that an increase in ROS levels induced by stimulation with RANKL may upregulate 
Nrf2. It has also been reported that Nrf2 regulates Keap1 by controlling its transcription [39–41].
Decreasing translation through miRNA can modulate downregulation of Nrf2. The down-
regulation of Nrf2 may be modulated by decreasing translation by miARN or by modifying 
the mRNA stability Nrf2. Bach1 is an inhibitor of Nrf2 binding to ARE. This inhibitor is impli-
cated in the mechanism indicated by the inhibited osteoclastogenesis discovered in Bach1 
knockout mice [38]. In conclusion, the Keap1/Nrf2 axis regulates RANKL-dependent osteo-
clastogenesis both by modulating intracellular ROS signals and by expressing cytoprotective 
enzymes. Elucidation of the precise mechanism linking Nrf2 to stimulation with RANKL may 
be a therapeutic treatment for destructive bone disorders through the Keap1-Nrf2 axis [42].
4. Oxidative stress in the establishment of bone disease
4.1. Osteoporosis
The human aging implies a failure in bone formation and a loss of bone mass, but the specific 
molecular mechanisms arbitrating these effects are still unclear. Numerous studies in experimental 
animals have offered arguments for a damaging effect of oxidative stress in bone tissue, support-
ing the idea that an increase in reactive oxygen species (ROS) with advancing age characterizes a 
pathophysiological mechanism essential in age-related bone damage. The disproportion between 
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bone resorption and formation with age is related to various factors. A reduced wall width repre-
sents the most common histological feature in aged human bone due to a reduced deposition of 
bone matrix related to an insufficient number of osteoblasts involved in bone remodeling [43, 46]. 
It was found that the low number of osteoblasts in the aging bone is correlated with a decrease in 
the number of mesenchymal stem cells and improper proliferation and differentiation of progeni-
tor cells [45]. An additional histologic feature of aged human bone tissue is a decrease in osteocyte 
density in the structure of bone lamellae accompanied by a mineralization of osteocyte lacunae. 
The precise mechanism of this phenomenon—named micropetrosis—is not very well known, but 
it seems to contribute to the decrease in osteocyte density with age [44–46].
The histopathological examination reveals thinned bone trabeculae that lose continuity being 
separated from each other by enlarged areolae with adipose degeneration of the marrow. 
The reduction of the trabecular connectivity is related to osteoporosis stages. The decrease 
of the medullar cellularity together with its enhancement in fat cells has negative outcomes 
on the bone. The areolar spaces are stretched, bordered by incomplete bone septa. This fact 
could be explained by the decrease of the connectivity of the bone trabeculae that will lead to 
the connection of the areolae by the osteolysis of certain walls (Figures 9 and 10).
Figure 9. Osteoporotic bone—hematoxylin-eosin (HE) stain.
Figure 10. Osteoporotic bone—trichromic Goldner-Szekely stain.
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4.2. Bone tumor development
Healthy people have a balance between bone formation and bone resorption. In various bone 
diseases, even in malignancy, loss of this balance leads to damage to the normal structural 
integrity of the skeleton [47, 48]. Tumor cells act by excessive stimulation of both osteoclasts 
and osteoblasts.
Oxidative stress is one of the most important events that gives rise to the conditions lead-
ing to tumor onset and progression [49]. Reactive oxygen species (ROS) is one of the most 
important species of free radicals. ROS controls many cellular processes, including cell 
proliferation, and thus stimulates the uncontrolled cell growth which may lead to tumor 
development [50]. In the case of chronic inflammation, the secretion of ROS may lead to 
the amplification of dysregulated processes and eventually to the development of a pre-
neoplastic state.
When the endogenous antioxidant response is exceeded by the amount of ROS produced, 
oxidative damage can occur in the lipids, proteins, and DNA. These lesions can lead to 
genetic alterations and ultimately to dysregulation of suppressor genes. Since oxidative 
stress and chronic inflammation processes are linked, failure to block these processes can 
lead to the initiation of carcinogenesis through genetic alterations [51]. In patients who have 
cancer, low total antioxidant capacity can be detected even before oncological treatment is 
started [52].
4.3. Diabetes-associated bone complications
Diabetic patients have been shown to increase lipid peroxidation and decrease the activity 
of erythrocyte antioxidant enzymes. Hyperglycemia is due to impaired insulin secretion in 
T1DM and insulin resistance in T2DM.
In hyperglycemic conditions, oxidative stress occurs as a result of the increased activity of the 
polyol pathway [53], the hexosamine pathway [54–56], and the promotion of the activator of 
protein kinase C [57]. Hyperglycemia also leads to a higher activation of the nuclear-kappa 
B (NF-κB), by protein kinase C in vitro. The nuclear factor-kappa B is a central transcription 
factor involved in the regulation of many proinflammatory genes, including cytokines (TNF-
tumor necrosis factor, interleukin) and hematopoietic growth factors [58]. Under hypergly-
cemic conditions, the NADH/NAD + cytosolic ratio increases because sorbitol is oxidized by 
NAD +. In this situation, the activation of the glyceraldehyde-3-phosphate dehydrogenase 
enzyme is inhibited. Although there is still little research, type 1 diabetes has been associated 
with osteoporosis. Therefore, we can say that type 1 diabetes may increase the risk of fractures 
[59]. Type 1 diabetes affects both bone density and bone quality [60, 61]. In T2DM, BMD is 
equal or increased according a meta-analysis, but the fracture risk is increased despite this 
increase in BMD [62, 63].
Osteocalcin (OST) is the second structural protein after collagen, a component of bone tissue, 
mainly involved in the process of bone mineralization and calcium homeostasis. It is synthe-
sized by osteoblasts, under the action of vitamins K and D3, from a pre-pro-osteocalcin pre-
cursor made up of 98 amino acids. Clinical research has shown that serum osteocalcin levels 
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are significantly lower in patients with type 2 diabetes, becoming normal after improved 
glycemic control. Osteocalcin is an independent factor associated with glucose and glycated 
hemoglobin for menopausal women.
It has been revealed that diabetes causes a reduction in the number of osteoblasts [64]. 
Diabetes can affect bone-forming cells through increased apoptosis. Like in this study from 
2007, authors found that AGEs induced apoptosis of osteoblasts through the MAP kinase 
pathway [65]. Another mechanism by which diabetes is associated with bone formation is the 
reduction in the expression of transcription factors involved in the regulation of osteoblast 
differentiation [66]. Studies in rats with diabetes showed a decrease in both alkaline phospha-
tase activity and the formation of the mineralized matrix [67, 68].
RAGE, the AGE receptor, is expressed at higher osteoblast levels in rats with diabetes, thus 
rendering the animals more susceptible to AGEs effects [69].
Some enzymes called serine kinases can be induced by oxidative stress. Their induction affects 
the ability of insulin to activate protein kinase B and glucose transport. When insulin action is 
impaired, diabetic complications may occur. In this context, the NF-κB, p38 MAPK, and JNK/
SAPK pathways are sensitive to oxidative stress [70].
A considerable amount of evidence has accumulated indicating that metabolic and endocrine 
alterations caused by diabetes affect bone quantity and quality over the last decades of life [71].
Hyperglycemia-induced oxidative stress is a major contributor in the development of long-
term complications of diabetes mellitus [72–75].
5. Conclusion
In this chapter we discussed about the role of oxidative stress in bone pathophysiology and 
the possibility of ROS production being a relevant therapeutic target under certain conditions.
Bone remodeling is a process of continuous formation and resorption occurring in specific areas 
of the matrix. Novel therapeutic strategies have been developed that focused on the inhibition 
of excessive bone resorption and promotion of bone formation process. As in this study from 
2017 [47], the author proposed as osteoblast inhibitors in dexamethasone (Dex)-induced apop-
tosis the synthetic derivatives of benzo[1,2,5]selenadiazole (SeDs). These compounds may have 
a protective effect. Dex treatment leads to overproduction of ROS in the cells, DNA fragmen-
tation, caspase-3/caspase-9 activation, p53 phosphorylation, and MAPK-pathway activation. 
When cells were pretreated with SeDs, these modifications were blocked, suggesting to the 
authors that SeDs may present a therapeutic application to antagonize osteoporosis induced by 
glucocorticoids [47]. Accordingly, basic research can contribute to the identification of specific 
pathways that can be effectively targeted by novel compounds able to treat and possibly reverse 
osteoporosis, particularly which occur in already chronically severed patients, such as in neuro-
degenerative disorders. In conclusion, we have shown that osteoclast differentiation and bone 
resorption are associated with the generation of ROS and oxidative stress. These data also indi-
cate that by reducing bone resorption, antioxidants have the potential to treat osteoporosis.
Reactive Oxygen Species and Bone Fragility
http://dx.doi.org/10.5772/intechopen.72305
61
Author details
Nina Filip1*, Elena Cojocaru2, Alexandru Filip3, Bogdan Veliceasa3 and Ovidiu Alexa3
*Address all correspondence to: zamosteanu_nina@yahoo.com
1 Department of Biochemistry, University of Medicine and Pharmacy “Grigore T. Popa”, 
Iasi, Romania
2 Department of Morphopathology, University of Medicine and Pharmacy “Grigore T. Popa”, 
Iasi, Romania
3 Department of Orthopaedic and Traumatology, University of Medicine and Pharmacy 
“Grigore T. Popa”, Iasi, Romania
References
[1] Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. 
International Journal of Biomedical Science: IJBS. 2008;4(2):89-96
[2] Southorn PA, Powis G. Free radicals in medicine. II. Involvement in human disease. 
Mayo Clinic Proceedings. 1988;63(4):390-408
[3] Rahman K. Studies on free radicals, antioxidants, and co-factors. Clinical Interventions 
in Aging. 2007;2(2):219
[4] Angeloni C, Maraldi T, Vauzour D. Redox signaling in degenerative diseases: From 
molecular mechanisms to health implications. BioMed Research International. 2014; 
2014:2. Article ID 245761. Available from: http://dx.doi.org/10.1155/2014/245761
[5] Pivonka P, Buenzli PR, Dunstan CR. In: Gowder S editor, A Systems Approach to 
Understanding Bone Cell Interactions in Health and Disease, Cell Interaction. InTech; 
2012. DOI: 10.5772/51149. Available from: https://www.intechopen.com/books/cell-
interaction/a-systems-approach-to-understanding-bone-cell-interactions-in-health-and-
disease
[6] Riggs BL, Parfitt AM. Drugs used to treat osteoporosis: The critical need for a uniform 
nomenclature based on their action on bone remodeling. Journal of Bone and Mineral 
Research. 2005 Feb 1;20(2):177-184
[7] Filip C, Albu E, Lupascu D, Filip N. The influence of a new rutin derivative in an 
experimental model of induced hyperhomocysteinemia in rats. Farmacia. 2017 Jul 1; 
65(4):596-599
[8] Albu E, Lupascu D, Filip C, Jaba IM, Zamosteanu N. The influence of a new rutin deriva-
tive on homocysteine, cholesterol and total antioxidative status in experimental diabetes 
in rat. Farmacia. 2013;61(6):1167-1177
Reactive Oxygen Species (ROS) in Living Cells62
[9] Graf E. Oxygen removal. U.S. Patent No. 5,284,871. 8 Feb. 1994
[10] David E. Biochemistry. Metzler, The Chemical Reaction of Living Cells. 2nd ed. Elsevier 
Academic Press; 2001
[11] McKee T, McKee JR. Biochemistry: The Molecular Basis of Life. Oxford: Oxford 
University Press; 2012
[12] Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of 
aerobic life. Plant Physiology. 2006;141(2):312-322
[13] Misra PH, Fridovici I. The generation of superoxide radical during the autoxidation of 
hemoglobin. The Journal of Biological Chemistry. 1972;247(21):6960-6962
[14] Bogdanova A, Petrushanko I, Boldyrev A, Gassmann M. Oxygen-and redox-induced 
regulation of the Na/K ATPase. Current Enzyme Inhibition. 2006;2(1):37-59
[15] Koppenol WH. The Haber-Weiss cycle–70 years later. Redox Report. 2001;6(4):229-234
[16] Mwebi NO. Fenton & Fenton-like Reactions: The Nature of Oxidizing Intermediates 
Involved. Diss. 2005
[17] Bray WC, Gorin MH. Ferryl ion, a compound of tetravalent iron. Journal of the American 
Chemical Society. 1932;54(5):2124-2125
[18] Bogdanova AY, Nikinmaa M. Reactive oxygen species regulate oxygen-sensitive 
potassium flux in rainbow trout erythrocytes. The Journal of General Physiology. 
2001;117(2):181-190
[19] Chemizmu K, Fentona R. Fenton reaction-controversy concerning the chemistry. 
Ecological Chemistry and Engineering. 2009;16:347-358
[20] Prousek J. Fenton chemistry in biology and medicine. Pure and Applied Chemistry. 
2007;79(12):2325-2338
[21] Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogen-
esis. Fibrogenesis & Tissue Repair. 2008;1(1):5
[22] Richards RS, Wang L, Jelinek H. Erythrocyte oxidative damage in chronic fatigue syn-
drome. Archives of Medical Research. 2007;38(1):94-98
[23] Martindale JL, Holbrook NJ. Cellular response to oxidative stress: Signaling for suicide 
and survival. Journal of Cellular Physiology. 2002;192(1):1-15
[24] Chen Z et al. MAP kinases. Chemical Reviews. 2001;101(8):2449-2476
[25] Powers SK et al. Reactive oxygen species are signalling molecules for skeletal muscle 
adaptation. Experimental Physiology. 2010;95(1):1-9
[26] Dröge W. Free radicals in the physiological control of cell function. Physiological 
Reviews. 2002;82(1):47-95
Reactive Oxygen Species and Bone Fragility
http://dx.doi.org/10.5772/intechopen.72305
63
[27] Heinrich PC, Müller M, Graeve L, editors. Löffler/Petrides Biochemie und Pathobio-
chemie. Springer-Verlag; 2014
[28] Cristiana F, Nina Z, Elena A. Homocysteine in red blood cells metabolism-pharma-
cological approaches. In: Blood Cell-An Overview of Studies in Hematology. InTech; 
2012
[29] Vacek TP, Kalani A, Voor MJ, Tyagi SC, Tyagi N. The role of homocysteine in bone 
remodeling. Clinical Chemistry and Laboratory Medicine. 2013;51:579-590. DOI: 
10.1515/cclm-2012-0605
[30] Kular J, Tickner J, Chim SM, Xu J. An overview of the regulation of bone remodel-
ling at the cellular level. Clinical Biochemistry. 2012;45(12):863-873. DOI: 10.1016/j.
clinbiochem.2012.03.021
[31] Park K, Ju WC, Yeo JH, Kim JY, Seo HS, Uchida Y, et al. Increased OPG/RANKL ratio 
in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced 
osteoclast differentiation. International Journal of Molecular Medicine. 2014;33:178-184. 
DOI: 10.3892/ijmm.2013.1557
[32] Park SK, Oh S, Shin HK, Kim SH, Ham J, Song JS, et al. Synthesis of substituted triazolyl cur-
cumin mimics that inhibit RANKL-induced osteoclastogenesis. Bioorganic & Medicinal 
Chemistry Letters. 2011;21:3573-3577. DOI: 10.1016/j.bmcl.2011.04.106
[33] Sun SC. The noncanonical NF-κB pathway. Immunological Reviews. 2012;246:125-140. 
DOI: 10.1111/j.1600-065X.2011.01088.x
[34] Soysa NS, Alles N, Weih D, Lovas A, Mian AH, Shimokawa H, et al. The pivotal role 
of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and 
osteoclastogenesis. Journal of Bone and Mineral Research. 2010;25:809-818. DOI: 10.1359/
jbmr.091030
[35] Piva R, Penolazzi L, Borgatti M, Lampronti I, Lambertini E, Torreggiani E, et al. 
Apoptosis of human primary osteoclasts treated with molecules targeting nuclear 
factor-kappaB. Annals of the New York Academy of Sciences. 2009;1171:448-456. DOI: 
10.1111/j.1749-6632.2009.04906.x
[36] Kaunitz JD, Yamaguchi DT. TNAP, TrAP, ecto-purinergic signaling, and bone remodel-
ing. Journal of Cellular Biochemistry. 2008;105:655-662. DOI: 10.1002/jcb.21885
[37] Augustine M, Horwitz MJ. Parathyroid hormone and parathyroid hormone-related pro-
tein analogs as therapies for osteoporosis. Current Osteoporosis Reports. 2013;11:400-406. 
DOI: 10.1007/s11914-013-0171-2
[38] Kanzaki H, Shinohara F, Kajiya M, Kodama T. The Keap1/Nrf2 protein axis plays a 
role in osteoclast differentiation by regulating intracellular reactive oxygen species 
signaling. Journal of Biological Chemistry. 2013;288:23009-230020. DOI: 10.1074/jbc.
M113.478545
Reactive Oxygen Species (ROS) in Living Cells64
[39] Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress 
responses, the hormesis paradigm and vitagenes: Novel targets for therapeutic interven-
tion in neurodegenerative disorders. Antioxidants & Redox Signaling. 2010d;13:1763-
1811. DOI: 10.1089/ars.2009.3074
[40] Zhang Y, Ahn YH, Benjamin IJ, Honda T, Hicks RJ, Calabrese V, et al. HSF1-dependent 
upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE path-
way. Chemistry & Biology. 2011;18:1355-1361. DOI: 10.1016/j.chembiol.2011.09.008
[41] Zhang Y, Naidu DS, Kostov RV, Pheely A, Calabrese V, Dinkova-Kostova AT. Sulfhydryl-
reactive phytochemicals as dual activators of transcription factors NRF2 and HSF1. 
In: Gang DR, editor. Recent Advances in Phytochemistry, 50 Years of Phytochemistry 
Research. New York, NY: Springer; 2014. pp. 95-119
[42] Cornelius C et al. Osteoporosis and Alzheimer pathology: Role of cellular stress response 
and hormetic redox signaling in aging and bone remodeling. Frontiers in Pharmacology. 
2014;5:120. DOI: 10.3389/fphar.2014.00120
[43] Parfitt AM. Bone-forming cells in clinical conditions. In: Hall BK, editor. Bone, The 
Osteoblast and Osteocyte. Vol. 1. Boca Raton, FL: Telford Press and CRC Press; 1990. 
pp. 351-429
[44] Busse B, Djonic D, Milovanovic P, et al. Decrease in the osteocyte lacunar density accom-
panied by hypermineralized lacunar occlusion reveals failure and delay of remodeling 
in aged human bone. Aging Cell. 2010;9:1065-1075
[45] Manolagas SC, Parfitt AM. What old means to bone. Trends in Endocrinology & Metab
olism. 2010;21:369-374
[46] Almeida M, O’Brien CA. Basic biology of skeletal aging: Role of stress response path-
ways. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences. 
2013;68(10):1197-1208
[47] Du Y et al. Selenadiazole derivatives antagonize glucocorticoid-induced osteoblasts cells 
apoptosis by blocking ROS-mediated signaling, a new anti-osteoporosis strategy. RSC 
Advances. 2017;7(47):29656-29664
[48] Seeman E, Delmas PD. Bone quality—The material and structural basis of bone strength 
and fragility. New England Journal of Medicine. 2006;354(21):2250-2261
[49] Sosa V, Moliné T, Somoza R, et al. Oxidative stress and cancer: An overview. Ageing 
Research Reviews. 2013;12(1):376-390
[50] Nourazarian AR, Kangari P, Salmaninejad A. Roles of oxida-tive stress in the devel-
opment and progression of breast cancer. Asian Pacific Journal of Cancer Prevention. 
2014;15(12):4745-4751
[51] Murata M, Thanan R, Ma N, et al. Role of nitrative and oxi-dative DNA damage in 
inflammation-related carcinogenesis. Journal of Biomedicine and Biotechnology. 2012; 
2012:623019
Reactive Oxygen Species and Bone Fragility
http://dx.doi.org/10.5772/intechopen.72305
65
[52] Vallet-Regi M. Mechanisms of Muscle Weakness Associated with Bone Metastases. 
International Journal of Cancer and Oncology. 2017;4(2):1-5
[53] Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation Research. 
2010;107(9):1058-1070
[54] Yerneni KK, Bai W, Khan BV, et al. Hyperglycemia-induced activation of nuclear tran-
scription factor kappaB in vascular smooth muscle cells. Diabetes. 1999;48(4):855-864
[55] Kolm-Litty V, Sauer U, Nerlich A, et al. High glucose-induced transforming growth fac-
tor beta1 production is mediated by the hexosamine pathway in porcine glomerular 
mesangial cells. Journal of Clinical Investigation. 1998;101(1):160-169
[56] Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose 
stimulation of transforming growth factor-alpha gene transcription. Journal of Biological 
Chemistry. 1996;271(25):15237-15243
[57] Yan LJ. Pathogenesis of chronic hyperglycemia: From reductive stress to oxidative stress. 
Journal of Diabetes Research. 2014;2014:137919
[58] Bulger EM, Maier RV. Antioxidants in critical illness. Archives of Surgery. 2001;136(10): 
1201-1207. DOI: 10.1001/archsurg.136.10.1201
[59] Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with 
type 1 and type2 diabetes—A meta-analysis. Osteoporosis International. 2007;18:427-444
[60] Wedrychowicz A, Stec M, Sztefko K, Starzyk JB. Associations between bone, fat tis-
sue and metabolic control in children and adolescents with type 1 diabetes mellitus. 
Experimental and Clinical Endocrinology & Diabetes. 2014;122(08):491-495. DOI: 10.1055/s- 
0034-1375666
[61] Kordonouri O et al. Other complications and diabetes-associated conditions in children 
and adolescents. Pediatric Diabete. 2014;15(Suppl 20):270-278
[62] Janghorbani M et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of 
fracture. American Journal of Epidemiology. 2007;166(5):495-505
[63] Li J et al. FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction 
of osteoblastogenesis and bone mass in type 2 diabetes mellitus. Scientific Reports. 
2015;5:12724. DOI: 10.1038/srep12724
[64] Lozano D, de Castro LF, Dapía S et al. Role of parathyroid hormone-related protein in 
the decreased osteoblast function in diabetes-related osteopenia. Endocrinology 2009; 
150(5):2027-2035
[65] Alikhani M, Alikhani Z, Boyd C, et al. Advanced glycation end products stimulate 
osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone. 
2007;40(2):345-353
[66] Lu H, Kraut D, Gerstenfeld LC, et al. Diabetes interferes with the bone formation by 
affecting the expression of transcription factors that regulate osteoblast differentiation. 
Endocrinology. 2003;144(1):346-352
Reactive Oxygen Species (ROS) in Living Cells66
[67] Hamann C, Goettsch C, Mettelsiefen J, et al. Delayed bone regeneration and low bone 
mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired 
osteoblast function. American Journal of Physiology-Endocrinology and Metabolism. 
2011;301(6):E1220-E1228
[68] Weinberg E, Maymon T, Moses O, et al. Streptozotocin-induced diabetes in rats dimin-
ishes the size of the osteoprogenitor pool in bone marrow. Diabetes Research and Clinical 
Practice. 2014;103(1):35-41
[69] Santana RB, Xu L, Chase HB, et al. A role for advanced glycation end products in dimin-
ished bone healing in type 1 diabetes. Diabetes. 2003;52(6):1502-1510
[70] Wu Y-Y, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal 
disease. International Journal of Oral Science. 2015;7(2):63
[71] Valkusz Z. Diabetes and osteoporosis. Orvosi Hetilap. 2011;152(29):1161-1166 Hungarian
[72] Lotfy M et al. Chronic complications of diabetes mellitus: A mini review. Current 
Diabetes Reviews. 2017;13(1):3-10
[73] Wu H et al. Diabetes-induced oxidative stress in endothelial progenitor cells may be 
sustained by a positive feedback loop involving high mobility group box-1. Oxidative 
Medicine and Cellular Longevity. 2016;2016:9. Article ID 1943918. Available from: http://
dx.doi.org/10.1155/2016/1943918
[74] Filip C, Ungureanu D, Nechifor C, Matei V, Chelărescu D, Caruntu ID, Florea C, 
Nechifor M. The role of some prostaglandin analogues in experimental intoxication pro-
duced by carbon tetrachloride in rats. Revista Medico-chirurgicala a Societatii de Medici 
si Naturalisti din Iasi. 2003;107(2):388-392
[75] Filip C, Albu E, Gheorghita N, Ghitler N, Mocanu G, Nechifor M. Hypolipidemic effect 
of a pro-drug containing nicotinic acid in rats. Open Medicine. 2006 Dec 1;1(4):348-355
Reactive Oxygen Species and Bone Fragility
http://dx.doi.org/10.5772/intechopen.72305
67

